For gastrointestinal stromal tumor, the prevalence of the KIT mutation was similar between the two groups, but our cohort had a significantly higher prevalence of CDKN2A and NF1 (Figure 1C). The gene discussed is CDKN2A; the disease is gastrointestinal stromal tumor.